Wasting cash—the decline of the British biotech sector

被引：0

作者：

Graham Smith

Muhammad Safwan Akram

Keith Redpath

William Bains

机构：

[1] Graham Smith is at East Grinstead,Department of Chemical Engineering and Biotechnology

[2] West Sussex,Department of Chemical Engineering and Biotechnology as well as Rufus Scientific Ltd.

[3] UK.,undefined

[4] Muhammad Safwan Akram is at the Institute of Biotechnology,undefined

[5] Tennis Court Road,undefined

[6] Cambridge,undefined

[7] UK.,undefined

[8] Keith Redpath is at JM Finn Capital Markets Ltd.,undefined

[9] London,undefined

[10] UK.,undefined

[11] William Bains is at the Institute of Biotechnology,undefined

[12] Melbourn,undefined

[13] Royston,undefined

[14] Herts,undefined

[15] UK.,undefined

来源：

Nature Biotechnology | 2009年 / 27卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Undercapitalization and overgenerous boardroom compensation for management have been major contributors to the poor performance of UK biotech.

引用

页码：531 / 537

页数：6

共 50 条